UBS Group’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-87,637
Closed -$200K 9017
2024
Q2
$200K Buy
87,637
+87,329
+28,354% +$199K ﹤0.01% 4544
2024
Q1
$1.33K Sell
308
-2,872
-90% -$12.4K ﹤0.01% 6986
2023
Q4
$9.7K Buy
3,180
+2,967
+1,393% +$9.05K ﹤0.01% 6267
2023
Q3
$307 Sell
213
-2,501
-92% -$3.61K ﹤0.01% 7449
2023
Q2
$6.76K Sell
2,714
-3,587
-57% -$8.93K ﹤0.01% 6262
2023
Q1
$16.9K Sell
6,301
-1,682
-21% -$4.51K ﹤0.01% 6115
2022
Q4
$43.3K Sell
7,983
-48,000
-86% -$261K ﹤0.01% 5739
2022
Q3
$700K Buy
55,983
+55,770
+26,183% +$697K ﹤0.01% 3113
2022
Q2
$1K Sell
213
-222,706
-100% -$1.05M ﹤0.01% 8990
2022
Q1
$1.69M Sell
222,919
-34,800
-14% -$264K ﹤0.01% 2796
2021
Q4
$2.63M Buy
257,719
+137,157
+114% +$1.4M ﹤0.01% 2663
2021
Q3
$1.62M Buy
120,562
+105,274
+689% +$1.41M ﹤0.01% 2902
2021
Q2
$335K Sell
15,288
-51,183
-77% -$1.12M ﹤0.01% 4009
2021
Q1
$1.6M Buy
66,471
+66,258
+31,107% +$1.59M ﹤0.01% 2957
2020
Q4
$4K Sell
213
-5,000
-96% -$93.9K ﹤0.01% 6908
2020
Q3
$60K Buy
5,213
+3,648
+233% +$42K ﹤0.01% 4668
2020
Q2
$38K Sell
1,565
-9,161
-85% -$222K ﹤0.01% 5266
2020
Q1
$118K Sell
10,726
-16,684
-61% -$184K ﹤0.01% 4294
2019
Q4
$725K Sell
27,410
-39,261
-59% -$1.04M ﹤0.01% 3607
2019
Q3
$1.52M Buy
66,671
+49,598
+291% +$1.13M ﹤0.01% 2856
2019
Q2
$524K Buy
17,073
+16,360
+2,295% +$502K ﹤0.01% 3511
2019
Q1
$12K Sell
713
-93,428
-99% -$1.57M ﹤0.01% 5867
2018
Q4
$1.8M Buy
94,141
+86,380
+1,113% +$1.65M ﹤0.01% 2524
2018
Q3
$406K Buy
7,761
+5,568
+254% +$291K ﹤0.01% 3781
2018
Q2
$95K Buy
2,193
+1,093
+99% +$47.3K ﹤0.01% 4603
2018
Q1
$40K Sell
1,100
-254
-19% -$9.24K ﹤0.01% 5031
2017
Q4
$27K Buy
1,354
+954
+239% +$19K ﹤0.01% 5369
2017
Q3
$10K Sell
400
-495
-55% -$12.4K ﹤0.01% 5986
2017
Q2
$15K Buy
+895
New +$15K ﹤0.01% 5558